BABA
Alibaba Group Holding Ltd - ADR
-20.42%
$105.11 - $83.65
Feb 8th 2023 - Mar 22nd 2023
Mar, 15, 2023
great for long term value.
Mar, 14, 2023
$BABA even the bears here believe in the long term... See more
SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Jan, 11, 2023
I’m holding long term because I truly believe this... See more
Jan, 6, 2023
SAVA can now compare/contrast their results with B... See more
SLRX
Salarius Pharmaceuticals Inc
-8.52%
$2.23 - $2.04
Feb 8th 2023 - Mar 22nd 2023
Mar, 15, 2023
great for long term value.
Mar, 14, 2023
$BABA even the bears here believe in the long term of baba stay strong bulls
Mar, 13, 2023
$BABA seems like a good day to buy long term calls.
Mar, 7, 2023
$BABA china standing up for themselves is a very long term bullish sign.
Feb, 25, 2023
The covid reopening after 3 years is big tailwind with all support from Govt in terms of monetary/fiscal policy.
Feb, 24, 2023
Longer term yes it's a buy
Feb, 24, 2023
$BABA looks to be forming a longer term bottom here (inverse h s) I’m liking this chart
Feb, 23, 2023
$BABA this will probably do well long term once Russia and China merge together.
Feb, 23, 2023
Positive earnings setup long term growth.
Feb, 23, 2023
$BABA long term this a gift !
Jan, 11, 2023
I’m holding long term because I truly believe this is the first effective Alz treatment to date.
Jan, 6, 2023
SAVA can now compare/contrast their results with BIIB and (hopefully) look the superior for it in terms of efficacy and safety.
Dec, 20, 2022
Long term calls ❤️
Dec, 20, 2022
but this thing long term looks incredible.
Dec, 15, 2022
$SAVA This will be fine in the short term.
Dec, 14, 2022
$SAVA 💯+ GAP UP when the Data comes out and $500+ Long term 💰
Dec, 14, 2022
$SAVA 💯+ GAP UP when the Data comes out and $500+ Long term 📶
Dec, 13, 2022
$SAVA 💯+ GAP UP when the Data comes out and $500+ Long term 📶
Dec, 13, 2022
$SAVA Looking good, getting longer term Jan 20th $60 calls small starter for a swing
Dec, 11, 2022
$BIVI Biovie Pharmaceuticals $BIVI passes Zacks Equity Research's strict "Recent Price Strength screen", and comes out with glowing colors--and a prediction of further momentum for the stock in near term.